Company News Hub
Flow Neuroscience News
No direct newsroom story is tagged to Flow Neuroscience yet. Use this page with the linked company profile and hub routes to keep the chronology tied to the broader market context.
Coverage Snapshot: Flow Neuroscience
Flow Neuroscience is currently mapped as a Mental Healthcare company at the Series A stage, with operating context centered on Sweden. The company summary on this route is: Flow Neuroscience develops direct current stimulation device and behavioral therapy app for depression. Mental Healthcare Medical Devices
What's Already Mapped
- Funding context: $1.00M, latest mapped round Series A (Khosla Ventures, $1M Series A in 2021).
- Founder coverage: Flow Neuroscience Team
- Market lens: Mental Healthcare | Series A | Sweden.
- Hiring watch: active role clusters include Open Roles.
Connected Routes
Related topics
Use the story feed below for chronology, then bounce back to the company profile and hub pages when you need peer, geography, or stage-level comparison.
No direct newsroom stories yet
We have not mapped a direct tagged article to Flow Neuroscience yet. In practice, that usually means the coverage is currently showing up inside broader mental healthcare or market-wide stories rather than on a single company-specific route.
- Start with the company profile for the cleanest summary of current company data.
- Check Sweden newsroom for geography-specific momentum.
- Compare peers through Mental Healthcare startup pages and Series A funding coverage.
